A Therapeutic Strategy for Preferential Targeting of TET2-Mutant and TET Dioxygenase–Deficient Cells in Myeloid Neoplasms

TET2 is frequently mutated in myeloid neoplasms. Genetic TET2 deficiency leads to skewed myeloid differentiation and clonal expansion, but minimal residual TET activity is critical for survival of neoplastic progenitor and stem cells. Consistent with mutual exclusivity of TET2 and neomorphic IDH1/2...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Blood Cancer Discov
Päätekijät: Guan, Yihong, Tiwari, Anand D., Phillips, James G., Hasipek, Metis, Grabowski, Dale R., Pagliuca, Simona, Gopal, Priyanka, Kerr, Cassandra M., Adema, Vera, Radivoyevitch, Tomas, Parker, Yvonne, Lindner, Daniel J., Meggendorfer, Manja, Abazeed, Mohamed, Sekeres, Mikkeal A., Mian, Omar Y., Haferlach, Torsten, Maciejewski, Jaroslaw P., Jha, Babal K.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Association for Cancer Research 2020
Aiheet:
Research Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7935131/
https://ncbi.nlm.nih.gov/pubmed/33681816
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2643-3230.BCD-20-0173
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia